Obesity Clinical Trial
— D-tectOfficial title:
D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life
Verified date | November 2017 |
Source | Bispebjerg Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Vitamin D deficiency is common among otherwise healthy pregnant women and may have
consequences for them as well as the early development and long-term health of their
children. However, the importance of maternal vitamin D status has not been widely studied.
The present study is divided into a societal experiment (1) and a case-cohort study (2):
1. The present study includes an in-depth examination of the influence of exposure to
vitamin D early in life and during critical periods of growth for development of type 1
diabetes (T1D), type 2 diabetes, gestational diabetes, pre-eclampsia, obesity, asthma,
arthritis, cancer, mental and cognitive disorders, congenital disorders, dental caries
and bone fractures during child- and adulthood. The study is based on the fact that
mandatory fortification of margarine with vitamin D, which initiated in 1937, was
terminated in 1985.
Apart from determining the influences of exposure prior to conception and during pre-
and postnatal life, the investigators examined the importance of vitamin D exposure
during specific seasons and trimesters, by comparing disease incidence among individuals
born before and after the fortification.
2. Additionally, a validated method was used to determine neonatal vitamin D status using
stored dried blood spots (DBS) from individuals who develop the aforementioned disease
entities as adults and their time and gender-matched controls.
Unparalleled, the study will help determine the effects of vitamin D exposure during critical
periods in life. There are a sufficient number of individuals to verify any effects during
different gestation phases and seasons of the year. The results, which will change our
current understanding of the significance of vitamin D, will enable new research in related
fields, including interventional research designed to assess supplementation needs for
different subgroups of pregnant women. Also, other health outcomes can subsequently be
studied to generate multiple new interdisciplinary health research opportunities involving
vitamin D.
Status | Completed |
Enrollment | 222776 |
Est. completion date | September 30, 2016 |
Est. primary completion date | September 30, 2016 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: 1. Born in Denmark around the fortification period 2. Sufficient amount of blood from the DBS Exclusion Criteria: 1.Born outside Denmark 1. Born outside the fortification period 2. Insufficient amount of blood from the DBS or DBS not found |
Country | Name | City | State |
---|---|---|---|
Denmark | Parker Institute | Frederiksberg |
Lead Sponsor | Collaborator |
---|---|
Bispebjerg Hospital | The Danish Council for Strategic Research |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cancers | Register based | 2018-2025 | |
Other | Mental disorders | Register based | 2018-2025 | |
Other | Dental caries | Register based | 2018-2025 | |
Other | Congenital disorders | Register based | 2018-2025 | |
Primary | Obesity | Register based | 2012-2025 | |
Primary | Type 1 diabetes | Register based | 2012-2016 | |
Primary | Pre-eclampsia | Register based | 2012-2025 | |
Primary | Bone facture | Register based | 2012-2025 | |
Secondary | Type 2 diabetes | Register based | 2014-2025 | |
Secondary | Gestational diabetes | Register based | 2014-2025 | |
Secondary | Asthma | Register based | 2015-2025 | |
Secondary | Arthritis | Register based | 2018-2025 | |
Secondary | Birth weight | Register based | 2014-2019 | |
Secondary | Mental diseases | Register based | 2012-2025 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |